| DPL-NV-LLC |
DPL-NV-LLC |
92%
|
On April 20, 2023, the Company and Digipath Labs entered into an Asset Purchase Agreement (the “Purchase Agreement”) with DPL NV, LLC ("Buyer"), pursuant to which Digipath Labs |
| INVICTUS-WEALTH-GROUP |
INVICTUS-WEALTH-GROUP |
90%
|
On December 8, 2022 (the "Transaction Date"), the Company entered into an Asset Purchase Agreement with Invictus Wealth Group ("Invictus"), whereby the Company agreed to sell certain collateralized e… |
| LWAY |
Lifeway Foods, Inc. |
72%
|
presence by adopting strategies such as investing in joint ventures, partnerships, mergers and acquisitions and research and development in innovative product lines. Although we do not believe there … |
| LWAY |
Lifeway Foods, Inc. |
72%
|
Reciprocal relationship from LWAY graph: Reciprocal relationship from FUNI graph: presence by adopting strategies such as investing in joint ventures, partnerships, mergers and acquisitions and resea… |
| APPLIED-FOOD-SCIENCES-INC |
APPLIED-FOOD-SCIENCES-INC |
62%
|
presence by adopting strategies such as investing in joint ventures, partnerships, mergers and acquisitions and research and development in innovative product lines. Although we do not believe there … |
| COLOMBIA-SUBSIDIARY-VSSL-ENTERPRISES-LTD |
COLOMBIA-SUBSIDIARY-VSSL-ENTERPRISES-LTD |
62%
|
pha Labs, Inc.(formerly Digipath, Inc.) (1) Nevada Parent Hypha Products, Inc. Nevada Subsidiary Digipath Labs, Inc. Nevada Subsidiary Digipath Labs CA, Inc. (2) California Subsidiary Digipath Labs S… |
| DIGIPATH-LABS-INC |
DIGIPATH-LABS-INC |
62%
|
ssets $ - $ 6,076 Warrants issued for debt financing $ - $ 93,938 Common stock issued for settlement of related party accrued compensation $ - $ 138,000 The accompanying notes are an integral part of… |
| ENTITY-INCORPORATION-RELATIONSHIP-HYPHA-LABS-INC |
ENTITY-INCORPORATION-RELATIONSHIP-HYPHA-LABS-INC |
62%
|
$ 82,200 $ 21,093 Supplemental disclosures: Interest paid $ - $ - Income taxes paid $ - $ - Non-cash investing and financing activities: Amortization of deferred offering costs $ 2,297 $ - See accomp… |
| NEVADA-SUBSIDIARY-DIGIPATH-LABS-CA-INC |
NEVADA-SUBSIDIARY-DIGIPATH-LABS-CA-INC |
62%
|
pha Labs, Inc.(formerly Digipath, Inc.) (1) Nevada Parent Hypha Products, Inc. Nevada Subsidiary Digipath Labs, Inc. Nevada Subsidiary Digipath Labs CA, Inc. (2) California Subsidiary Digipath Labs S… |
| NEVADA-SUBSIDIARY-DIGIPATH-LABS-INC |
NEVADA-SUBSIDIARY-DIGIPATH-LABS-INC |
62%
|
pha Labs, Inc.(formerly Digipath, Inc.) (1) Nevada Parent Hypha Products, Inc. Nevada Subsidiary Digipath Labs, Inc. Nevada Subsidiary Digipath Labs CA, Inc. (2) California Subsidiary Digipath Labs S… |
| OPTIMI-HEALTH-CORP |
OPTIMI-HEALTH-CORP |
62%
|
presence by adopting strategies such as investing in joint ventures, partnerships, mergers and acquisitions and research and development in innovative product lines. Although we do not believe there … |
| Q-OVERVIEW-HYPHA-LABS-INC |
Q-OVERVIEW-HYPHA-LABS-INC |
62%
|
er 30, 2025 in the section entitled “Risk Factors” for a description of certain risks that could, among other things, cause actual results to differ from these forward-looking statements. We assume n… |
